Zobrazeno 1 - 10
of 236
pro vyhledávání: '"PHiD-CV"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
Background In response to the substantial clinical and economic burden of diseases caused by Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) in Tunisia, the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D
Externí odkaz:
https://doaj.org/article/cddce0097de54bbb90675bec9de910c3
Autor:
Amit Bhavsar, Janusz Zaryczański, Anna Wasilewska, Delphine Saragoussi, Raghavendra Devadiga, Chris Colby, Enas Bahar, Jacek Wysocki
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
As infection with Streptococcus pneumoniae is an important cause of pneumonia in children, the World Health Organization recommends childhood pneumococcal conjugate vaccines (PCVs). In January 2017, PCV universal mass vaccination (UMV) was introduced
Externí odkaz:
https://doaj.org/article/a5302aa0cd0340f9ab40f45bea99c2a6
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 5, Pp 1463-1469 (2021)
As a stepping stone toward evaluation in infants, the safety and immunogenicity of an investigational 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (12vPHiD-CV) was assessed in toddlers. 12vPHiD-CV contains CR
Externí odkaz:
https://doaj.org/article/b8a15ff274df49e28fdf8982d5eac4c5
Autor:
Gabriel Carrasquilla, Alexandra Porras-Ramírez, Sandra Martinez, Rodrigo DeAntonio, Raghavendra Devadiga, Carla Talarico, Diana C. Caceres, Maria M. Castrejon, Patricia Juliao
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 4, Pp 1173-1180 (2021)
In Colombia, pneumococcal conjugate vaccines (PCVs) were implemented into the infant universal mass vaccination program in a stepwise manner; PCV-7 between 2009 and 2011 in different geographic regions/cities, with nationwide introduction of a 10-val
Externí odkaz:
https://doaj.org/article/6f8cffc451194047bb0a5409166bf902
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
The worldwide implementation of pneumococcal conjugate vaccines (PCVs) in children has reduced the overall pneumococcal disease burden. Two PCVs are widely available for infant vaccination: the pneumococcal non-typeable Haemophilus influenzae protein
Externí odkaz:
https://doaj.org/article/e7e8c051894e44108026f09e5e0f850a
Autor:
Soon Min Lee, Jang Hoon Lee, Eun Song Song, Sung Jin Kim, Joon Hyung Kim, Rupert W. Jakes, Raghavendra Devadiga, Moon Sung Park
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 12, Pp 3019-3025 (2018)
In 2010, Korea introduced 10-valent pneumococcal conjugate vaccine for children aged 6 weeks to 5 years against invasive disease caused by Streptococcus pneumoniae serotypes 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F and cross-reactive 19A. The aim of th
Externí odkaz:
https://doaj.org/article/e5785d6caeec4b138d23b7ce8ab45c35
Autor:
Kerry-Ann F. O'Grady, Anne B. Chang, Allan Cripps, Edward K. Mulholland, Heidi Smith-Vaughan, Nicholas Wood, Margaret Danchin, Ruth Thornton, Andrew Wilson, Paul J. Torzillo, Peter M. Morris, Peter Richmond, Sheree Rablin, Daniel Arnold, Ann Connor, Vikas Goyal, Tanya Stoney, Kirsten Perrett, Keith Grimwood
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 11, Pp 2768-2779 (2018)
We aimed to determine the efficacy of the 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in children aged 18-months to
Externí odkaz:
https://doaj.org/article/b2459db1e6074f1eaf764e79f34f09de
Publikováno v:
Infectious Diseases and Therapy, Vol 7, Iss 4, Pp 535-538 (2018)
Externí odkaz:
https://doaj.org/article/081b550ab1af4058b002b1a72a4b7d7d
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 9, Pp 797-818 (2018)
Introduction: Pneumococcal diseases (including septicemia, meningitis, pneumonia, and upper respiratory infections) constitute a major public health problem. The World Health Organization recommends pneumococcal conjugate vaccine immunization of youn
Externí odkaz:
https://doaj.org/article/d9b490393f384a3780369588927ace39
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 14, Iss 1, Pp 85-94 (2018)
Background: Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) can cause invasive pneumococcal diseases (IPD), pneumonia, and acute otitis media (AOM). Both the 10-valent pneumococcal NTHi protein D conjugate vaccine (PHiD-CV) an
Externí odkaz:
https://doaj.org/article/6366888e35cc4811a55afc21b2bcba2f